chr15:63060899:G>A Detail (hg38) (TPM1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr15:63,353,098-63,353,098 View the variant detail on this assembly version. |
hg38 | chr15:63,060,899-63,060,899 |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_001018007.1:c.523G>A | NP_001018007.1:p.Asp175Asn |
NM_000366.5:c.523G>A | NP_000357.3:p.Asp175Asn | |
NM_001330351.1:c.415G>A | NP_001317280.1:p.Asp139Asn |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 1 |
GWAS entry | |
Disease area statistics | Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
other |
![]() |
MGS000001
(TMGS000154) |
Kenjiro Kosaki | Keio University |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2023-05-24 | criteria provided, multiple submitters, no conflicts | hypertrophic cardiomyopathy 3 |
![]() ![]() |
Detail |
![]() |
2015-11-04 | criteria provided, single submitter | Primary familial hypertrophic cardiomyopathy |
![]() |
Detail |
![]() |
2023-02-24 | criteria provided, multiple submitters, no conflicts | not provided |
![]() |
Detail |
![]() |
2024-01-17 | criteria provided, multiple submitters, no conflicts | hypertrophic cardiomyopathy |
![]() ![]() |
Detail |
![]() |
2023-12-15 | criteria provided, single submitter |
![]() |
Detail | |
![]() |
2022-10-04 | criteria provided, multiple submitters, no conflicts | cardiomyopathy |
![]() |
Detail |
![]() |
2016-01-01 | criteria provided, single submitter | dilated cardiomyopathy 1Y |
![]() |
Detail |
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.034 | hypertrophic cardiomyopathy | Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -t... | BeFree | 10900175 | Detail |
0.360 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3 (disorder) | NA | CLINVAR | Detail | |
0.034 | hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift... | BeFree | 21376702 | Detail |
0.002 | Cardiomyopathies | To understand how the HCM-causing Asp175Asn and Glu180Gly mutations in α-tropomy... | BeFree | 22155441 | Detail |
0.002 | Hyperlipoproteinemia Type IIa | The long-range decreases in dynamic stability due to these two single-site mutat... | BeFree | 22794249 | Detail |
0.248 | Cardiomyopathy, Hypertrophic, Familial | Cardiac α-tropomyosin (Tm) single-site mutations D175N and E180G cause familial ... | BeFree | 22794249 | Detail |
0.127 | Cardiomyopathies | To understand how the HCM-causing Asp175Asn and Glu180Gly mutations in α-tropomy... | BeFree | 22155441 | Detail |
0.001 | Hyperlipoproteinemia Type IIa | In this work we have (1) used ATPase studies using reconstituted thin filaments ... | BeFree | 22794249 | Detail |
0.127 | Cardiomyopathies | In conclusion, in HCM attributable to the Asp175Asn mutation in the alpha-tropom... | BeFree | 14734051 | Detail |
0.127 | Cardiomyopathies | Rest-stress first-pass MR imaging with gadopentetate dimeglumine was performed i... | BeFree | 12511681 | Detail |
0.127 | Cardiomyopathies | 95 unselected subjects with mild-to-moderate hypertension, 24 patients with HCM ... | BeFree | 21274714 | Detail |
0.006 | hypertrophic cardiomyopathy | In conclusion, in patients with nonobstructive HC attributable to an Asp175Asn m... | BeFree | 18394456 | Detail |
0.054 | hypertrophic cardiomyopathy | Genotype-phenotype correlative studies have implicated 8 particular mutations th... | BeFree | 12473556 | Detail |
0.011 | hypertrophic cardiomyopathy | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic ... | BeFree | 24888384 | Detail |
0.034 | hypertrophic cardiomyopathy | In contrast, prognosis reflected genotype; near normal life expectancy is found ... | BeFree | 9060904 | Detail |
<0.001 | Precursor B-cell lymphoblastic leukemia | Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on le... | BeFree | 18394456 | Detail |
0.034 | hypertrophic cardiomyopathy | Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on le... | BeFree | 18394456 | Detail |
0.248 | Cardiomyopathy, Hypertrophic, Familial | We studied the clinical and genetic features of familial hypertrophic cardiomyop... | BeFree | 9060904 | Detail |
0.156 | hypertrophic cardiomyopathy | Genotype-phenotype correlative studies have implicated 8 particular mutations th... | BeFree | 12473556 | Detail |
0.127 | Cardiomyopathies | The extent of myocardial contractile impairment is strongly and independently re... | BeFree | 16014439 | Detail |
0.005 | Cardiomyopathies | The TPM1-D175N and MYBPC3-Q1061X mutations account for a substantial part of all... | BeFree | 22462493 | Detail |
0.034 | hypertrophic cardiomyopathy | Cine MR imaging of myocardial contractile impairment in patients with hypertroph... | BeFree | 16014439 | Detail |
<0.001 | Left Ventricular Hypertrophy | In HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, myo... | BeFree | 17556170 | Detail |
0.248 | Cardiomyopathy, Hypertrophic, Familial | The results allow us to propose a hypothesis of the pathogenetic changes caused ... | BeFree | 15031138 | Detail |
0.034 | hypertrophic cardiomyopathy | Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patien... | BeFree | 17556170 | Detail |
0.034 | hypertrophic cardiomyopathy | To assess first-pass magnetic resonance (MR) imaging in the evaluation of perfus... | BeFree | 12511681 | Detail |
0.034 | hypertrophic cardiomyopathy | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic ... | BeFree | 24888384 | Detail |
0.002 | Hyperlipoproteinemia Type IIa | The haplotypes of three kindreds with FHC due to an alpha-tropomyosin gene mutat... | BeFree | 9060904 | Detail |
0.127 | Cardiomyopathies | In HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, myo... | BeFree | 17556170 | Detail |
0.248 | Cardiomyopathy, Hypertrophic, Familial | NA | CLINVAR | Detail | |
0.034 | hypertrophic cardiomyopathy | Inducibility of life-threatening ventricular arrhythmias is related to maximum l... | BeFree | 14734051 | Detail |
0.127 | Cardiomyopathies | The TPM1-D175N and MYBPC3-Q1061X mutations account for a substantial part of all... | BeFree | 22462493 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Hypertrophic cardiomyopathy 3 | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Primary familial hypertrophic cardiomyopathy | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND not provided | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Hypertrophic cardiomyopathy | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Cardiovascular phenotype | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Cardiomyopathy | ClinVar | Detail |
NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn) AND Dilated cardiomyopathy 1Y | ClinVar | Detail |
Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175As... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands... | DisGeNET | Detail |
To understand how the HCM-causing Asp175Asn and Glu180Gly mutations in α-tropomyosin affect on actin... | DisGeNET | Detail |
The long-range decreases in dynamic stability due to these two single-site mutations suggest increas... | DisGeNET | Detail |
Cardiac α-tropomyosin (Tm) single-site mutations D175N and E180G cause familial hypertrophic cardiom... | DisGeNET | Detail |
To understand how the HCM-causing Asp175Asn and Glu180Gly mutations in α-tropomyosin affect on actin... | DisGeNET | Detail |
In this work we have (1) used ATPase studies using reconstituted thin filaments in solution to show ... | DisGeNET | Detail |
In conclusion, in HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, life-thr... | DisGeNET | Detail |
Rest-stress first-pass MR imaging with gadopentetate dimeglumine was performed in 17 patients with H... | DisGeNET | Detail |
95 unselected subjects with mild-to-moderate hypertension, 24 patients with HCM attributable to the ... | DisGeNET | Detail |
In conclusion, in patients with nonobstructive HC attributable to an Asp175Asn mutation in the alpha... | DisGeNET | Detail |
Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophi... | DisGeNET | Detail |
In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM)... | DisGeNET | Detail |
In contrast, prognosis reflected genotype; near normal life expectancy is found in hypertrophic card... | DisGeNET | Detail |
Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remod... | DisGeNET | Detail |
Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remod... | DisGeNET | Detail |
We studied the clinical and genetic features of familial hypertrophic cardiomyopathy (FHC) caused by... | DisGeNET | Detail |
Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophi... | DisGeNET | Detail |
The extent of myocardial contractile impairment is strongly and independently related to LV mass and... | DisGeNET | Detail |
The TPM1-D175N and MYBPC3-Q1061X mutations account for a substantial part of all HCM cases in the Fi... | DisGeNET | Detail |
Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy at... | DisGeNET | Detail |
In HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, myocardial oxidative me... | DisGeNET | Detail |
The results allow us to propose a hypothesis of the pathogenetic changes caused by alpha-tropomyosin... | DisGeNET | Detail |
Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic... | DisGeNET | Detail |
To assess first-pass magnetic resonance (MR) imaging in the evaluation of perfusion impairment in a ... | DisGeNET | Detail |
In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM)... | DisGeNET | Detail |
The haplotypes of three kindreds with FHC due to an alpha-tropomyosin gene mutation, Asp175Asn, were... | DisGeNET | Detail |
In HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, myocardial oxidative me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thic... | DisGeNET | Detail |
The TPM1-D175N and MYBPC3-Q1061X mutations account for a substantial part of all HCM cases in the Fi... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs104894503 dbSNP
- Genome
- hg38
- Position
- chr15:63,060,899-63,060,899
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
Genome browser